Bumper Offer - Urjas oil Just @ Rs. 1
Alfa Sincal Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Alfa Sincal Tablet is used -
Moderate
Mild
Unknown
Is the use of Alfa Sincal Tablet safe for pregnant women?
There are no side effects of Alfa Sincal Tablet in pregnant women.
Is the use of Alfa Sincal Tablet safe during breastfeeding?
Alfa Sincal Tablet is completely safe for breastfeeding women.
What is the effect of Alfa Sincal Tablet on the Kidneys?
Alfa Sincal Tablet is not harmful for kidneys.
What is the effect of Alfa Sincal Tablet on the Liver?
Alfa Sincal Tablet is not harmful for the liver.
What is the effect of Alfa Sincal Tablet on the Heart?
There are no any side effects of Alfa Sincal Tablet for the heart.
Alfa Sincal Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Alfa Sincal Tablet unless your doctor advises you to do so -
Is this Alfa Sincal Tablet habit forming or addictive?
Forming a habit of Alfa Sincal Tablet has not been reported.
Interaction between Food and Alfa Sincal Tablet
When consumed with certain foods, Alfa Sincal Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Alfa Sincal Tablet
It is difficult to say anything about the effect of Alfa Sincal Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1276-1279
